Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -246.49M | -485.64M | -879.29M | -1.69B | -2.15B |
| Total Depreciation and Amortization | 96.45M | 134.63M | 175.05M | 204.19M | 226.09M |
| Total Amortization of Deferred Charges | 752.00K | 963.00K | 3.22M | 6.11M | 7.14M |
| Total Other Non-Cash Items | -336.63M | 28.40M | 393.28M | 1.17B | 1.64B |
| Change in Net Operating Assets | 551.03M | 481.05M | 409.64M | 540.46M | 478.66M |
| Cash from Operations | 65.11M | 159.40M | 101.89M | 228.74M | 205.19M |
| Capital Expenditure | -16.16M | -144.74M | -147.22M | -334.10M | -601.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 14.00M | -- | -- | -- | -- |
| Other Investing Activities | -833.00K | -92.00K | -409.00K | 10.55M | 10.88M |
| Cash from Investing | -3.00M | -144.83M | -147.63M | -323.55M | -590.78M |
| Total Debt Issued | -- | 45.17M | 45.09M | 179.20M | 261.35M |
| Total Debt Repaid | -44.65M | -42.94M | -81.91M | -118.93M | -143.61M |
| Issuance of Common Stock | -- | 25.05M | 25.05M | 25.05M | 25.05M |
| Repurchase of Common Stock | -- | -19.00K | -2.37M | -31.65M | -31.65M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -15.52M | -3.85M | 0.00 | 195.01M |
| Cash from Financing | -44.65M | 11.74M | -17.99M | 53.67M | 306.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.47M | 26.30M | -63.72M | -41.14M | -79.44M |